The estimated Net Worth of Sue Bailey is at least $3.16 Milion dollars as of 4 March 2021. Sue Bailey owns over 8,168 units of Emergent Biosolutions Inc stock worth over $184,912 and over the last 17 years he sold EBS stock worth over $2,640,591. In addition, he makes $338,000 as Independent Director at Emergent Biosolutions Inc.
Sign up
Sue Bailey EBS stock SEC Form 4 insiders trading
Sue has made over 10 trades of the Emergent Biosolutions Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 8,168 units of EBS stock worth $754,478 on 4 March 2021.
The largest trade he's ever made was exercising 19,920 units of Emergent Biosolutions Inc stock on 12 May 2015 worth over $199,997. On average, Sue trades about 3,991 units every 79 days since 2007. As of 4 March 2021 he still owns at least 24,427 units of Emergent Biosolutions Inc stock.
You can see the complete history of Sue Bailey stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sue Bailey biography
Dr. Sue Bailey, M.D., is an Independent Director of the Company. Dr. Bailey served as a news analyst for NBC Universal, a media and entertainment company, from November 2001 to August 2006. Previously, Dr. Bailey served as Administrator, National Highway Traffic Safety Administration, as Assistant Secretary of Defense (Health Affairs) and as Deputy Assistant Secretary of Defense (Clinical Services). Dr. Bailey is a former faculty member at Georgetown Medical School and U.S. Navy officer, having achieved the rank of Lt. Commander, U.S. Navy Reserve. Dr. Bailey received her D.O. from Philadelphia College of Osteopathic Medicine and a B.S. from the University of Maryland. Bailey's qualifications to serve on our Board of Directors include her medical background and prior senior positions in government.
What is the salary of Sue Bailey?
As the Independent Director of Emergent Biosolutions Inc, the total compensation of Sue Bailey at Emergent Biosolutions Inc is $338,000. There are 17 executives at Emergent Biosolutions Inc getting paid more, with Robert Kramer having the highest compensation of $3,693,820.
How old is Sue Bailey?
Sue Bailey is 76, he's been the Independent Director of Emergent Biosolutions Inc since 2007. There are 2 older and 18 younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
What's Sue Bailey's mailing address?
Sue's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.
Insiders trading at Emergent Biosolutions Inc
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over $131,382,266 worth of Emergent Biosolutions Inc stock and bought 4,647 units worth $138,981 . The most active insiders traders include Seamus Mulligan, Fuad El Hibri a Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of $147,206. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth $61,100.
What does Emergent Biosolutions Inc do?
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
What does Emergent Biosolutions Inc's logo look like?
Complete history of Sue Bailey stock trades at Emergent Biosolutions Inc
Emergent Biosolutions Inc executives and stock owners
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include:
-
Robert Kramer,
President, Chief Executive Officer, Director -
Fuad El-Hibri,
Executive Chairman of the Board -
Robert G. Kramer,
CEO, Pres & Exec. Director -
Richard Lindahl,
Chief Financial Officer, Executive Vice President, Treasurer -
Atul Saran,
Executive Vice President, Corporate Development, General Counsel and Corporate Secretary -
Adam Havey,
Executive Vice President - Business Operations -
Fuad El-Hibri,
Founder & Exec. Chairman -
Richard S. Lindahl,
Exec. VP, CFO & Treasurer -
Adam R. Havey,
Exec. VP & COO -
Atul Saran,
Exec. VP of Corp. Devel. & Ext. Affairs and Gen. Counsel -
Seamus Mulligan,
Director -
Ronald Richard,
Lead Independent Director -
Zsolt Harsanyi,
Independent Director -
Louis Sullivan,
Independent Director -
Jerome Hauer,
Independent Director -
George Joulwan,
Independent Director -
Kathryn Zoon,
Independent Director -
Sue Bailey,
Independent Director -
Marvin White,
Director -
Robert Burrows,
Vice President, Investor Relations -
Sean Kirk,
Executive Vice President, Manufacturing and Technical Operations -
Katherine Strei,
Executive Vice President, Human Resources and Communications, Chief Human Resources Officer -
Katherine Strei,
Exec. VP of HR & Chief HR Officer -
Nina DeLorenzo,
Sr. VP of Global Communications & Public Affairs -
Lynn Kieffer,
VP of Corp. Communications -
Howard Anderson,
Sr. VP & Chief Information Officer -
Karen L. Smith,
EVP, Chief Medical Officer -
John Niederhuber,
Director -
Daniel Abdun Nabi,
SVP Corp Aff, GC & Secretary -
L.L.C. Bio Pharm,,
10% owner -
Stephen Lockhart,
SVP Product Development -
L.L.C. Intervac,,
10% owner -
Steven Chatfield,
President, EPD UK & CSO -
R Don Elsey,
VP Finance, CFO & Treasurer -
Barry Labinger,
EVP, Biosciences Div. -
Denise Esposito,
SVP Legal Affairs & GC -
L.L.C. Biologika,,
-
Biologic Products, Inc. Mic...,
-
Kyle Keese,
SVP Mktg & Comm. -
Joe M Allbaugh,
Director -
Mauro Gibellini,
SVP Corporate Dev. -
Investments Ltd Microscience,
10% owner -
Shahzad Malik,
Director -
Edward Arcuri,
EVP & COO -
Thomas Zink,
SVP & CMO -
Robert Calvin Myers,
-
Joseph C Papa,
President and CEO -
Jennifer Lynne Fox,
EVP, Ext Aff, GC, Corp Sec -
Keith Katkin,
Director -
Coleen Glessner,
EVP, Quality & Ethics, and CPL -
Sujata Tyagi Dayal,
Director -
Paul Anthony Williams,
SVP, Products Business -
William Hartzel,
SVP, Bioservices -
Neal Franklin Fowler,
Director -
Donald W De Golyer,
Director